Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the MRC-Human Immunology Unit, supported by the NIHR Oxford Biomedical Research Centre, have used an ‘atlas’ of immune cells in the human colon to find evidence of the role of CD8 T cells in inflammatory bowel disease. The findings could pave the way for more targeted treatments for this chronic disorder.

Woman on blurred background using digital x-ray of human intestine holographic scan projection 3D rendering

Similar stories

New study finds link between mild COVID-19 disease and certain T cell reponses

The study, led by researchers at the MRC Translational Immune Discovery Unit and the CAMS Oxford Institute (NDM), found that dominant T cell responses found in many individuals 4 years after infection are associated with mild COVID-19 disease, and likely play important protective roles in subsequent viral infection events.